Bibliografía del artículo
1. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. M7-A6. Wayne, PA: NCCLS, 2003.
2. Warren JW, Abrutyn E, Hebel JR, Johson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 29:745-58, 1999.
3. Naber KG, Bergman B, Bishop MC, Bjerklund-Johansen TE, Botto H, Lobel B, Jinenez Cruz F, Selvaggi F. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU). EAU guidelines for the management of urinary and male genital tract infections. Eur Urol 40:576-88, 2001.
4. Andreu A, Alós JI, Gobernado M, Marco F, De la Rosa M, García-JA y Grupo Cooperativo Español para el estudio de la sensibilidad antimicrobiana de los patógenos urinarios. Etiología y sensibilidad a los antimicrobianos de los uropatógenos causantes de la infección urinaria baja adquirida en la comunidad. Estudio nacional multicéntrico. Enferm Infecc Microbiol Clin 23:4-9, 2005.
5. Gómez J, Muñoz R, Baños V, Gómez G. Tratamiento de las infecciones urinarias adquiridas en el comunidad: prespectivas actuales y enfoque clinico del paciente. Rev Esp Quimioterap 18:319-27, 2005.
6. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: A nationwide analysis. Clin Infect Dis 33:89-94, 2001.
7. Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS Project. Int J of Antimicrob Agents 22:S49-S52, 2003.
8. Gordon KA, Jones RN. SENTRY Participant Groups (Europe, Latin America, North America). Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis 45:295-301, 2003.
9. Kahlmeter G. Prevalence and antimicrobial susceptibility of pathogens in uncomplicated cystitis in Europe. The ECO.SENS study. Int J Antimicrob Agents 22(Suppl 2):49-52, 2003.
10. Kahlmeter G, Menday P, Cars O. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection. J Antimicrob Chemother 52:1005-10, 2003.
11. Junquera S, Loza E, Baquero F. Evolución del patrón de sensibilidad de aislados de Escherichia coli en urocultivos procedentes del medio hospitalario y extrahospitalario. Enferm Infecc Microbiol Clin 23:197-201, 2005.
12. Zhanel GG, Hisanaga TL, Laing NM, DeCorby MR, Nichol KA, Weshnoweski B, Johnson J, Noreddim A, Low DE, Karlowsky JA, for the NAUTICA Group, Hoban DJ. Antibiotic resistence in Escherichia coli outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA). Int J Antimicrob Agents 27:468-75, 2006.
13. McNulty CAM, Richards J, Livermore DM, Little P, Charlett A, Freeman E, Harvey I, Thomas M. Clinical relevance of laboratory-reported anbtibiotic resistance in acute uncomplicated urinary tract infection in primary care. J Antimicrob Chemother 58:1000-8, 2006.
14. Alos JI, Serrano MG, GomésGarcés JL, Perianes J. Anbtibiotic resistance of Escherichia coli from community-acquired urinary tract infection in relation to demographic and clinical data. Clin Microbiol Infect 11:199-203, 2005.
15. Hooton TM, Besser R, Foxman B, Fritsche TR, Nicolle LE. Acute uncomplicated cystitis in an era of increasing antibiotic resistance: a proposed approach to empirical therapy. Clin infect Dis 39:75-80, 2004.
16 Hooton TM, Scholes D, Gupta K, Stapelton AE, Roberts PL, Stamm WE. Amoxicillin/clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. JAMA 293:949-55, 2005.
17. Iravini A, Eichard GA, Johnson D, Bryant A. A double-blind, multicenter, comparative study od the safety and efficacy of cefixime versus amoxicillin in the treatment of acute urinary tract infections in adult patients. Am J Med 85:17-23, 1988.
18. Hooton TM, Winter C, Tiu F, Stamm WE. Randomized comparative trial and cost analysis of 3-day antimicrobial regiments for treatment of acute cystitis in women. JAMA 273:41-45, 1995.
19. Horcajada JP, Garcia-Palomo D, Fariñas MC. Tratamiento de las infecciones no complicadas del tracto urinario inferior. Enf Infecc Microbiol Clin 23(Suppl 4):22-27, 2005.
20. Calbo E, Romaní V, Xercavins M, Gomez L, Garcia Vidal C, Quintana S, Vila J, Garau J. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum -lactamases. J Antimicrob Chemother 57:780-3, 2006.
21. Carlone NA, Borsotto M, Cuffini AM, Savoia D. Effect of fosfomycin trometamol on bacteria adhesion in camparison with other chemotherapeutic agents. Eur Urol 13(Suppl 1):86-91, 1987.
22. Ungheri D, Albini E, Belluco G. In vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol. J Chemother 14:237-40, 2002.
23. Pérez T, Andreu A, Sabaté M, Moreno M, Prats G. Sub-MIC Effects of fosfomycin and ciprofloxacin on the expression of type-1 fimbriae in Escherichia coli. 7th European Congress of Chemotherapy and Infection. Florencia 2005.
24. Oteo J, Lazaro E, de Abajo FJ, Baquero F and Campos J. Antimicrobial-resistant invasive Escherichia coli, Spain. Emerg Infect Dis 11:546-53, 2005.
25. Hernandez JR, Pascual A, Canton R, Martinez-Martinez L. Grupo de Estudio de Infección Hospitalaria GEIH. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals (GEIH-BLEE Project 2002)]. Enferm Infecc Microbiol Clin 21:77-82, 2003.
26. De Cueto M, Hernández JR, Lopez-Cerero L, Morillo C, Pascual A. Actividad de fosfomicina sobre cepas de Escherichia coli y Klebsiella pneumoniae productoras de betalactamasas de espectro extendido. Enferm Infecc Microbiol Clin 24:613-6, 2006.